Multisystemic inflammatory syndrome of the adult post-COVID-19.
Medicina Interna de Mexico
; 38(2):471-475, 2022.
Article
in Spanish
| EMBASE | ID: covidwho-2315328
ABSTRACT
BACKGROUND:
Multisystemic inflammatory syndrome of the adult, a new condition associated with an irregular immune response similar to that of children, is characterized by shock, heart failure or persistent hypotension, dyspnea on exertion, mild-moderate hypoxemia, gastric symptoms and elevated markers of systemic inflammation after severe COVID-19 pneumonia. CLINICAL CASE A 56-year-old patient, uncontrolled diabetic, who presented symptoms associated with dyspnea, desaturation, chest pain and persistent fever, previously with severe pneumonia after one month of treatment. He was treated with oxygen, steroids and antibiotics for 3 weeks, but his symptoms worsened and he developed severe orthopnea, hypotension, chest pain, dyspnea at rest and severe desaturation, as well as elevation of inflammation markers (C-reactive protein, ESR, D-dimer, ferritin). Tomography of the chest showed residual pneumonia based on consolidation and ground glass. Echocardiogram evidenced diastolic dysfunction, myopericarditis and secondary endocarditis. Multisystemic inflammatory syndrome of the adult was diagnosed and patient was treated with IV immunoglobulin and steroid with a favorable response to treatment. CONCLUSION(S) This case shows that the adult systemic inflammatory syndrome is a differential diagnosis in a patient with shock of unknown etiology, heart failure and severe dyspnea previously infected by SARS-CoV-2. Immunoglobulin and steroid are the effective first-line treatment with excellent clinical response.Copyright © 2022 Comunicaciones Cientificas Mexicanas S.A. de C.V.. All rights reserved.
covid-19; Immunoglobulin; Inflammation; SARS-CoV-2; adult; article; case report; clinical article; coronavirus disease 2019; diabetes mellitus; diastolic dysfunction; differential diagnosis; drug combination; drug therapy; dyspnea; echocardiography; endocarditis; fever; first-line treatment; heart failure; human; hypotension; male; middle aged; myopericarditis; nonhuman; pneumonia; Severe acute respiratory syndrome coronavirus 2; systemic inflammatory response syndrome; thorax pain; tomography; treatment response; antibiotic agent; C reactive protein; D dimer; endogenous compound; ferritin; glass; human immunoglobulin; oxygen; steroid
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Long Covid
Language:
Spanish
Journal:
Medicina Interna de Mexico
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS